Literature DB >> 28502889

Three-Dimensional Printing Facilitates Successful Endovascular Closure of a Type II Abernethy Malformation Using an Amplatzer Atrial Septal Occluder Device.

Jeffrey Forris Beecham Chick1, Shilpa N Reddy2, Alice C Yu3, Tatiana Kelil4, Ravi N Srinivasa5, Kyle J Cooper5, Wael E Saad5.   

Abstract

Type II Abernethy malformations, characterized by side-to-side portosystemic shunting with preserved intrahepatic portal venous system, have been treated with shunt closure surgically and endovascularly. Three-dimensional printing has been used to develop highly accurate patient-specific representations for surgical and endovascular planning and intervention. This innovation describes 3-dimensional printing to successfully close a flush-oriented type II Abernethy malformation with discrepant dimensions on computed tomography, conventional venography, and intravascular ultrasound, using a 12-mm Amplatzer atrial septal occluder device.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28502889     DOI: 10.1016/j.avsg.2017.02.012

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

Review 1.  Pediatric Portal Interventions.

Authors:  Rajiv N Srinivasa; Chick Jeffrey Forris Beecham; Noah Chen; Joseph J Gemmete; Wael A Saad; Narasimham L Dasika; Ravi N Srinivasa
Journal:  Semin Intervent Radiol       Date:  2018-06-04       Impact factor: 1.513

2.  Living donor liver transplantation for congenital absence of portal vein in portal venous reconstruction with a great saphenous vein graft.

Authors:  Peilin Li; Masaaki Hidaka; Takashi Hamada; Satoshi Ikeda; Shinichiro Ono; Yasuhiro Maruya; Tota Kugiyama; Takanobu Hara; Tomoko Yoshimoto; Tomohiko Adachi; Takayuki Tanaka; Takayuki Miyoshi; Shunsuke Murakami; Yu Huang; Kengo Kanetaka; Susumu Eguchi
Journal:  Surg Case Rep       Date:  2020-06-29

3.  A rare presentation of type II Abernethy malformation and nephrotic syndrome: Case report and review.

Authors:  Xin Wu; Weizhong Gu; Yongzhi Lin; Lina Ye
Journal:  Open Life Sci       Date:  2022-07-21       Impact factor: 1.311

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.